Intracellular Insulin and Impaired Autophagy in a Zebrafish Model and a Cell Model of Type 2 Diabetes
Overview
Authors
Affiliations
Type 2 diabetes mellitus is characterized by insulin resistance. However, the complete molecular mechanism remains unclear. In this study, zebrafish were fed a long-term high-fat diet to induce type 2 diabetes, which resulted in a higher body weight, body mass index, more lipid vacuoles in liver, increased insulin transcription level in liver, brain and muscle, and high fasting blood glucose in the high-fat diet zebrafish. Oppositely, the transcription levels of insulin substrate-2 and glucose transporter 2 were significantly decreased, indicating insulin signaling pathway and glucose transport impaired in the insulin-targeting tissues. Transcription of the autophagy-related genes, ATG3, ATG4B, ATG5, ATG7, ATG12, and FOXO3, were decreased but autophagy inhibitor gene m-TOR increased, and autophagy-flux was inhibited in liver of the high-fat diet zebrafish. Main of these changes were confirmed in palmitic acid-treated HepG2 cells. Further, in co-immunoprecipitation and subcellular co-localization experiments, the conjunction of preproinsulin with cargo-recognition protein p62 increased, but conjuncts of autophagosome with p62-cargo, lysosomes with p62-cargo, and autolysosomes decreased apparently. Interestingly, lysosomes, autolysosomes and conjuncts of p62-insulin localized at the periphery of palmitic acid-treated cells, the margination of lysosomes may mediate deactivation of proteases activity. These findings suggest that intracellular high-lipid may trigger defective autophagy, defective downstream signaling of insulin and accumulated intracellular preproinsulin, leading to dysregulation of cell homeostasis mechanism, which may be one of reasons involved in insulin-resistance in type 2 diabetes.
Autophagy-lysosome pathway in insulin & glucagon homeostasis.
Wu Y, Wang H, Xu H Front Endocrinol (Lausanne). 2025; 16:1541794.
PMID: 39996055 PMC: 11847700. DOI: 10.3389/fendo.2025.1541794.
Chen Z, Zhou Z, Deng Q, Zou Y, Wang B, Huang S Int J Mol Sci. 2025; 26(2.
PMID: 39859466 PMC: 11765840. DOI: 10.3390/ijms26020752.
Hui J, Du P, Webb S, Liu J, Ngan M, Lu Z PLoS One. 2024; 19(12):e0314515.
PMID: 39621609 PMC: 11611181. DOI: 10.1371/journal.pone.0314515.
mTOR Dysregulation, Insulin Resistance, and Hypertension.
Stanciu S, Jinga M, Miricescu D, Stefani C, Nica R, Stanescu-Spinu I Biomedicines. 2024; 12(8).
PMID: 39200267 PMC: 11351979. DOI: 10.3390/biomedicines12081802.
Roohi T, Faizan S, Shaikh M, Krishna K, Mehdi S, Kinattingal N Exp Physiol. 2024; 109(6):847-872.
PMID: 38279951 PMC: 11140176. DOI: 10.1113/EP091587.